Brief: Forte Biosciences Inc - Entered Into An At Market Issuance Sales Agreement With Ladenburg Thalmann & Co
01/04/2022 12:00
April 1 (Reuters) - Forte Biosciences Inc FBRX.O :
* FORTE BIOSCIENCES INC- ON MARCH 31, CO ENTERED INTO AN AT
MARKET
ISSUANCE SALES AGREEMENT WITH LADENBURG THALMANN & CO INC
* FORTE BIOSCIENCES INC- UNDER AGREEMENT, CO MAY OFFER AND
SELL
ITS COMMON STOCK HAVING AN AGGREGATE OFFERING PRICE OF UP TO $25
MILLION
* FORTE BIOSCIENCES- INTENDS TO USE NET PROCEEDS FROM
OFFERING
FOR GENERAL CORPORATE PURPOSES, FUNDING EXISTING, POTENTIAL NEW
CLINICAL PROGRAMS
Source text for Eikon: ID:
Further company coverage: FBRX.O
((Reuters.Briefs@thomsonreuters.com;))